Form 4: Tesla Director Exercises Options, Sells Shares

Tesla Director Kathleen Wilson-Thompson exercised stock options and subsequently sold a portion of the acquired shares under a pre-arranged trading plan.

Summary

• Tesla Director Kathleen Wilson-Thompson engaged in transactions involving Tesla common stock on February 25, 2026.
• She exercised 40,000 non-qualified stock options at an exercise price of $14.99 per share.
• Following the option exercise, she sold a total of 25,731 shares of common stock in multiple transactions.
• The sales occurred at weighted average prices ranging from $412.46 to $418.888 per share.
• These transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2025.
• After these transactions, Wilson-Thompson beneficially owns 19,669 shares of common stock directly and 80,948 non-qualified stock options.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. Insider sales under a 10b5-1 plan are routine and do not typically signal a change in company fundamentals or management's outlook.

Positives

• The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned, non-discretionary sale.
• The director exercised options at a significantly lower price ($14.99) than the market sale price (over $400), indicating a substantial personal gain.

Negatives

• A director selling a significant number of shares, even under a 10b5-1 plan, could be perceived negatively by some investors, though it is a common practice for compensation and diversification.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding Tesla's future performance or strategic direction, focusing solely on insider trading activities.

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales, are common for executives and directors as part of compensation and personal financial planning. The use of a Rule 10b5-1 plan indicates these sales were pre-scheduled and not based on immediate, non-public information, which is a standard practice to mitigate insider trading concerns. This type of filing is routine for publicly traded companies like Tesla, where directors often receive equity compensation.

Comparison to Industry Standards

• Insider sales under 10b5-1 plans are a standard practice across industries for executives and directors to manage their equity compensation and diversify their portfolios.
• For example, similar planned sales are routinely observed at tech giants like Apple (AAPL) or Amazon (AMZN), where executives often exercise vested options and sell shares.
• The scale of the transaction for Kathleen Wilson-Thompson is typical for a director's compensation and personal financial management at a large-cap company like Tesla.

Stakeholder Impact

• Shareholders: The sale of shares by a director could be interpreted in various ways, but given it's under a 10b5-1 plan, the direct impact on shareholder confidence is typically minimal as it's a pre-planned event for personal financial management.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions (option exercise and subsequent share sales) conducted under a pre-arranged 10b5-1 trading plan. Such transactions are common for directors managing their equity compensation and personal finances and do not typically reflect a change in the company's fundamental outlook or warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as this filing provides no new information to alter the investment thesis for Tesla.

Keywords

Tesla, TSLA, Kathleen Wilson-Thompson, Insider Trading, Form 4, Stock Options, Share Sale, 10b5-1 Plan, Director Transactions